Profil
Matthew W.
Emmens served as the Chief Executive Officer of Astra Merck, Inc. for 18 years and as the Chief Executive Officer of EMD Pharmaceuticals, Inc. for two years.
He also served as the President and Director of Merck KGaA for four years.
Emmens was the Chief Executive Officer of Shire Plc for five years and later served as its Non-Executive Chairman for two years.
He was also a Director at Incyte Corp.
for three years.
Emmens served as an Independent Director at Bristol Myers Squibb Co. for four years.
He was a Director at Shire Acquisition, Inc. and New River Pharmaceuticals, Inc. Emmens completed his undergraduate degree from Fairleigh Dickinson University.
Tidigare kända positioner av Matthew Emmens
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktör/Styrelseledamot | 2021-05-04 |
| SHIRE | Ordförande | 2014-04-29 |
| INCYTE CORPORATION | Direktör/Styrelseledamot | 2009-02-04 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Verkställande Direktör | 2008-05-23 |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direktör/Styrelseledamot | 2008-03-12 |
Matthew Emmenss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops novel products | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
















